In two double-blind, placebo-controlled trials, microdosing psilocybin did not produce consistent improvements in cognitive performance or mood. Participants (n ≈ 130 across both studies) showed no significant differences from placebo in attention, working memory, or emotional well-being after multiple weeks of dosing. While some reported mild positive experiences, these effects didn’t hold up statistically once placebo expectations were controlled for.